Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
832.6 USD | +0.16% | +3.06% | +42.83% |
06:35pm | Britain considers offering Lilly weight-loss drug on better terms than Wegovy | RE |
04:34pm | Eli Lilly: recruits Bristol Myers Quality Director | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.83% | 75TCr | |
+34.11% | 60TCr | |
-5.70% | 36TCr | |
+18.06% | 33TCr | |
+4.63% | 28TCr | |
+17.02% | 24TCr | |
+9.26% | 21TCr | |
-4.21% | 21TCr | |
+2.43% | 17TCr | |
+6.67% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and : Morgan Stanley Adjusts Eli Lilly's Price Target to $275 From $207, Reiterates Overweight Rating